Takeuchi, Masashi
Kawakubo, Hirofumi
Tsuji, Takayuki
Maeda, Yusuke
Matsuda, Satoru
Fukuda, Kazumasa
Nakamura, Rieko
Kitagawa, Yuko
Article History
Received: 25 May 2022
Accepted: 28 January 2023
First Online: 23 February 2023
Declarations
:
: Masashi Takeuchi, Hirofumi Kawakubo, Takayuki Tsuji, Yusuke Maeda, Satoru Matsuda, Kazumasa Fukuda, and Rieko Nakamura have no conficts of interest or fnancial ties to disclose. Yuko Kitagawa received lecture fees from CHUGAI PHARMACEUTICAL CO., LTD., TAIHO PHARMACEUTICAL CO., LTD, ASAHI KASEI PHARMA CORPORATION, Otsuka Pharmaceutical Factory Inc., SHIONOGI & CO., LTD., Nippon Covidien Inc., ONO PHARMACEUTICAL CO., LTD., Bristol-Myers Squibb K.K. Author Y.K was supported by grants from CHUGAI PHARMACEUTICAL CO., LTD., TAIHO PHARMACEUTICAL CO., LTD, Yakult Honsha Co. Ltd., AsahiKASEI Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., ONO PHARMACEUTICAL CO., LTD., TSUMURA & CO., Kyouwa Hakkou Kirin Co., Ltd., DAINIPPON SUMITOMO PHARMA Co., Ltd., EA Pharma Co., Ltd., Astellas Pharma Inc., Toyama Chemical Co., Ltd., MEDICON INC., KAKEN PHARMACEUTICAL CO. LTD., Eisai Co., Ltd., Otsuka Pharmaceutical Factory Inc., TEIJIN PHARMA LIMITED., NIHON PHARMACEUTICAL CO., LTD., and Nippon Covidien Inc. Author Y.K held an endowed chair provided by CHUGAI PHARMACEUTICAL CO., LTD. and TAIHO PHARMACEUTICAL CO., LTD, outside the submitted work.
Free to read: This content has been made available to all.